An immunohistochemical study of basal cell carcinoma and trichoepithelioma.

The histologic distinction between tricheopithelioma and basal cell carcinoma may be difficult in small biopsies. Immunohistochemical stains have been used to help make this distinction; however, published studies have generally been limited to a few antibodies. To this end we performed a comprehensive immunohistochemical analysis of 20 basal cell carcinomas and 10 tricheopitheliomas from our files, in search of a consistent pattern of reactivity to distinguish the neoplasms in biopsies. The antibodies used were: low molecular weight keratin (Cam 5.2), Cytokeratin 7, (CK7), Cytokeratin 20, (CK20), Carcino-embryonic antigen (CEA), CD30 (Ki-1), bcl-2, Ham 56, HPCA-I (CD34), and Ulex Europaeus type I. In our study, bcl-2 stained all but one basal cell carcinoma in a diffuse pattern, whereas all tricheopitheliomas showed staining of the outermost epithelial layer. No other stain proved to be an independent marker for either neoplasm and no consistent immunohistochemical profile for either neoplasm emerged. Thus, we conclude that bcl-2 may be of some value in distinguishing basal cell carcinoma from tricheopithelioma, limited by the quantitative nature of the difference in staining. Histologic criteria applied to H&E-stained sections remain the cornerstone of histologic diagnosis.

[1]  J. Ring,et al.  Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma. , 1998, The American Journal of dermatopathology.

[2]  M. Wick,et al.  Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens , 1998, Journal of cutaneous pathology.

[3]  T. Aramendi,et al.  Cutaneous lymphadenoma: an adnexal neoplasm with intralobular activated lymphoid cells. , 1998, The American Journal of dermatopathology.

[4]  W. Hartschuh,et al.  Merkel cells are absent in basal cell carcinomas but frequently found in trichoblastomas. An immunohistochemical study , 1997, Journal of cutaneous pathology.

[5]  J. Val-Bernal,et al.  Perianal basal cell carcinoma: a comparative histologic, immunohistochemical, and flow cytometric study with basaloid carcinoma of the anus. , 1996, The American Journal of dermatopathology.

[6]  B. Smoller,et al.  Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms , 1995, Journal of cutaneous pathology.

[7]  M. Rijn,et al.  bcl-2 expression in primary malignancies of the skin. , 1995, Archives of dermatology.

[8]  R. Brown,et al.  Utility of microwave-citrate antigen retrieval in diagnostic immunohistochemistry. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[9]  D. Bryant,et al.  Immunostaining for CD34 to determine trichoepithelioma. , 1995, Archives of dermatology.

[10]  R. Warnke,et al.  bcl‐2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas , 1994, The British journal of dermatology.

[11]  B. Smoller,et al.  CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. , 1994, Archives of dermatology.

[12]  I. Campbell,et al.  Keratin expression in normal skin and epidermal neoplasms demonstrated by a panel of monoclonal antibodies , 1992, Journal of cutaneous pathology.

[13]  M. Heng,et al.  Expression of Ulex europaeus Agglutinin I Lectin‐Binding Sites in Squamous Cell Carcinomas and Their Absence in Basal Cell Carcinomas: Indicator of Tumor Type and Differentiation , 1992, The American Journal of dermatopathology.

[14]  A. Ackerman,et al.  Infundibulocystic basal cell carcinoma: a newly described variant. , 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[15]  S. Pileri,et al.  BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. , 1989, Blood.

[16]  F. Stirpe,et al.  CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. , 1995, Blood.